SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Lupin settles litigation with Forest Labs for Alzheimer's drug

23 Dec 2009 Evaluate

Lupin has settled all its ongoing patent litigation with US-based Forest Laboratories on the Alzheimer’s disease treatment drug, Namenda (memantine tablets). By the settlement, Lupin will be licensed under the relevant patents and would be free to commercially launch its generic product in January, 2015, or earlier in certain circumstances.

 

Sources said Lupin is believed to be the first to challenge the patent of this drug, which had sales of $949 million in the US for the financial year 2009 and accounted for 26 percent of Forest’s net revenue last year.

 

Such out-of-court settlements are part of the generic drug business in the US. By US rules for launching a generic drug, the generic company has to file a marketing application named Abbreviated New Drug Application (ANDA) with the US Food and Drug Administration (FDA). If the ANDA challenges the patent of the innovator, that has to be notified to the company. Then, the innovator company has to sue the patent challenger within 45 days of receipt of notice, to prevent the FDA from approving the generic.

crackcrack

Lupin Share Price

2312.35 -20.35 (-0.87%)
13-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1652.00
Dr. Reddys Lab 1235.20
Cipla 1211.30
Zydus Lifesciences 923.10
Lupin 2312.35
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×